Contracts › 75A50325C00012
75A50325C00012: Bulk Pharma - Group a (ASSET MGMT) Doxycycline 25MG/5ML Oral Suspension, Powder, 60ML Bottle, Ondansetron Hcl 8MG, 30 Tablets, Bottle
Awarded to Chartwell Rx Llc by Office of Assistant Secretary for Preparedness and Response.
$16.1Mobligated
$42.8Mpotential value
31 August 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50325C00012 |
|---|---|
| Awardee | Chartwell Rx Llc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | ASPR/ORM-SNS |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | NY |
| Offers received | 1 |
| Period of performance | 01 September 2025 to 31 August 2026 |
| Potential end | 31 August 2030 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record